COVID-19 3rd Dose Vaccine in Transplant Patients
Clinical trial NCT05047640 · TERMINATED
Trial details
- NCT number
- NCT05047640
- Sponsor
- Giselle Guerra
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-14
- Primary completion
- 2022-10-25
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.